UPDATE 3-Merck to buy Austrian vaccine maker as it jumps into COVID-19 race

Merck & Co Inc, which has largely kept to the sidelines of the race for COVID-19 treatments, said it was buying Austrian vaccine maker Themis Bioscience and would collaborate with research nonprofit IAVI to develop two separate vaccines.